The indicative listing is predicated on points recognized and options made by audio system on the WTO webinar Regulatory Cooperation in the course of the COVID-19 Pandemic, on 2 June 2021, and the WTO symposium COVID-19 Vaccine Supply Chain and Regulatory Transparency, on 29 June 2021.
On trade-related bottlenecks, the listing identifies a sequence of points raised by audio system at these occasions in relation to: vaccine manufacturing and its inputs; vaccine regulatory approval; vaccine distribution; therapeutics and prescription drugs; and diagnostics and medical gadgets.
Regarding potential trade-facilitating measures, the listing contains options by audio system in reference to: common import, export and transit procedures; vaccine manufacturing and its inputs; vaccine regulatory approval; therapeutics (prescription drugs); diagnostics and medical gadgets; and common regulatory elements.
One widespread theme that emerges from the listing is that important items and inputs have to circulation effectively and expeditiously to assist the fast scaling up of COVID-19 manufacturing capability worldwide. The delay of a single element might considerably decelerate, and even halt, vaccine manufacturing given the globally built-in provide chains that underpin COVID-19 vaccine manufacturing.
The listing will not be meant to be an exhaustive listing of all particular commerce limitations, nor does it make any judgement on the existence or significance of bottlenecks, nor on the desirability of implementing any of the options on trade-facilitating measures.
The Secretariat indicative listing of “Trade-related bottlenecks and trade-facilitating measures on critical products to combat COVID-19” will be discovered here.